알림
CMS Public Engagement Announcement
- [등록자]Centers for Medicare & Medicaid Services (CMS)
- [언어]日本語
- [지역]Baltimore, MD
- 등록일 : 2025/03/03
- 게재일 : 2025/03/03
- 변경일 : 2025/03/03
- 총열람수 : 20 명
- 가게를 검색하고 싶을 땐 <타운가이드>
-
- 미국 전역에서 일본어를 구사하는 의료진과 환자를 연결하고, 일본인 커뮤니...
-
"FLAT ・ FLAT
후라토는 뉴욕을 거점으로 미국 전역에서 활동하는 비영리 단체로, 일본어를 구사하는 의료진과 환자를 연결하고 일본인 커뮤니티를 지원하고 있습니다. 미국에서 의료와 보험의 복잡성에 직면한 일본인과 그 간병인, 고령화에 따라 고립되는 시니어가 늘어나는 가운데, 우리는 필요한 정보와 지원을 제공하고 있습니다. 온라인 활동... +1 (772) 349-9459FLAT ・ふらっと
-
- 정신과 ・ 정신과 전문의 타카시 마츠키의 DC 사무소에 오신 것을 환영합...
-
전근, 유학, 국제결혼 등 다양한 이유로 매년 수많은 일본인이 미국에 오지만, 그 중 많은 사람들이 낯선 이국 생활, 새로운 직장이나 학교에서의 부적응, 문화와 언어의 장벽, 일본 가족이나 친구와의 이별 등 다양한 스트레스에 노출되어 있다. 강한 스트레스는 다양한 정신질환을 유발할 수 있습니다. 이런 증상이 있나요 ? 기분 저하, 피로감, 피로감, 기...
+1 (201) 809-3508精神科・心療内科医 松木隆志
-
- 워싱턴 DC ・ 버지니아 주 ・ 메릴랜드 주 ・ 코네티컷 주의 주치의 클...
-
일본을 떠나 미국에서 생활하는 분들에게 가장 걱정스럽고 중요한 것은 자신과 가족의 건강입니다. 뉴저지에 위치한 저희 클리닉에서는 내과, 소아과, 외과, 산부인과, 피부과, 안과, 이비인후과 등 모든 진료과를 진료하고 있습니다. 이번에 히바리 패밀리 메디컬은 뉴저지 주 외에도 워싱턴 DC, 버지니아, 메릴랜드, 코네티컷 주에서 원격 진료를 시작하게 되었습니다...
+1 (201) 581-8553ひばりファミリーメディカル
-
- 신입생 모집 중 ! ・ 주의 사항 : 워싱턴 DC 지역에는 학교가 없습니...
-
"미국에서도 'SAPIX' 수업을 들을 수 있어요 ! 게다가 ! 일본의 SAPIX와는 또 다른 'SAPIX USA'의 수업을 광역 워싱턴 DC에서도 들을 수 있어요 ! 일본으로의 진학 ・ 수험 그렇다면 사픽스에 맡겨주세요. 뉴욕교, 뉴저지교, 맨해튼교, 산호세교 수업을 온라인으로 수강할 수 있습니다 ! 주의 사항 : 워싱턴 DC 지역에는 학교 건...
+1 (914) 358-5337SAPIX USA
CMS will host a series of public engagement events this spring as part of the Medicare Drug Price Negotiation Program [ https://www.cms.gov/inflation-reduction-act-and-medicare/medicare-drug-price-negotiation ]. The virtual public engagement events will provide an opportunity for patients, beneficiaries, caregivers, consumer and patient organizations, and other interested parties, such as clinicians and researchers, to share input relevant to the drugs selected for the second cycle of negotiations.
CMS is interested in input relevant to the selected drugs, the condition(s) that the selected drug may be used to treat, and other medications that may be used to manage those conditions. This includes information related to the clinical benefits of the selected drugs compared to therapeutic alternatives, how the selected drugs address unmet need, and how the selected drugs impact specific populations.
CMS will use the information shared during the roundtable events to better understand *patients’ experiences with the conditions and diseases* treated by the selected drugs and *patients’ experiences with the selected drugs* themselves. CMS will use the information shared during the town hall meeting to better understand *clinicians’ experiences prescribing and/or managing treatment *with the selected drugs or therapeutic alternatives and *clinicians’ considerations that drive treatment choice* between the selected drugs and therapeutic alternatives. The information shared during both the town hall meeting and the roundtable events will also inform CMS’ identification of therapeutic alternatives, key outcomes, and adjustment of the starting point to develop the initial offer in negotiating with manufacturers of selected drugs. CMS will release redacted transcripts for the town hall meeting and each of the roundtable events, omitting participant names and other identifying information after all the events have ended.
*Dates:* The public engagement events will be held April 16 – April 30, 2025. Participant registration will be open until March 12, 2025.
*Attendance*: Anyone from the public may attend the town hall meeting livestream as a listener. Registration is not required, and the link to the livestream will be available here [ https://www.cms.gov/inflation-reduction-act-and-medicare/medicare-drug-price-negotiation/2027-public-engagement-events ] on April 30, 2025. Accommodation for people with disabilities and language assistance (e.g., interpretation) may be available.
*Public Input Opportunities*: There are two ways the public can share feedback and input with CMS:
* _Public Engagement Events:_
* CMS will host one livestreamed town hall meeting for all selected drugs, focused on the clinical considerations related to the selected drugs. CMS encourages practicing* clinicians and researchers*, as well as other interested parties, to register to speak.
* CMS will host 15 private (i.e., not livestreamed or open to press or general public) patient-focused roundtable events, one for each selected drug, which will be open to *patients, patient advocacy organizations, and caregivers* selected to speak at the events, and will allow for discussion among speakers.
Those who wish to make a public statement in the town hall meeting or to participate in a private roundtable event should *register for the opportunity to speak at the public engagement events*. Additional information to register for the events can be found here [ https://www.cms.gov/inflation-reduction-act-and-medicare/medicare-drug-price-negotiation/2027-public-engagement-events ]. For more information about the public engagement events, please see the Frequently Asked Questions document linked here [ https://www.cms.gov/files/document/pe-faq021925508-final.pdf ].
*If you are selected to speak* at the event for which you registered, *you will have 4 days after receiving the confirmation email* *to confirm your availability to participate *at the selected event date and time, and any language interpretation services you need.
* _Submitted Statement_: CMS encourages the public to *submit written input*, if interested, in response to the CMS request for information about selected drugs and evidence about alternative treatments. Information can be submitted here [ https://hpms.cms.gov/app/ng/pblc_cmt/ ] by 11:59 PM PT March 1, 2025.
The public engagement events are subject to change, including postponement and/or cancellation.
Additional information on the public engagement events can be found here [ https://www.cms.gov/inflation-reduction-act-and-medicare/medicare-drug-price-negotiation/2027-public-engagement-events ]. Additional information about the Medicare Drug Price Negotiation Program can be found here [ https://www.cms.gov/inflation-reduction-act-and-medicare/medicare-drug-price-negotiation ].
________________________________________________________________________
You're getting this message because you subscribed to get email updates from the Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov/ ].
Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page [ https://public.govdelivery.com/accounts/USCMS/subscriber/edit?preferences=true#tab1 ]. You will need to use your email address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com [ https://subscriberhelp.govdelivery.com/ ].
This service is provided to you at no charge by Centers for Medicare & Medicaid Services (CMS) [ http://www.cms.gov ].
________________________________________________________________________
This email was sent to mshinji3056@gmail.com using GovDelivery Communications Cloud 7500 Security Boulevard · Baltimore MD 21244
body .abe-column-block { min-height: 5px; } table.gd_combo_table img {margin-left:10px; margin-right:10px;} table.gd_combo_table div.govd_image_display img, table.gd_combo_table td.gd_combo_image_cell img {margin-left:0px; margin-right:0px;} table.govd_hr {min-width: 100%;}